Vasco Salgado Costa

Dr. Vasco Salgado Costa

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VCVasco Salgado Costa
Vasco Salgado Costa
JCJosé Cidade
José Cidade
IMInês Miguel de Noronha Medeiros
Inês Miguel de Noronha Medeiros
PPPedro Póvoa
Pedro Póvoa
The prompt identification and correction of patient–ventilator asynchronies (PVA) remain a cornerstone for ensuring the quality of respiratory failure treatment and the prevention of further injury to critically ill patients. These disruptions, whether due to over- or under-assistance, have a profound clinical impact not only on the respiratory mechanics and the mortality associated with mechanical ventilation but also on the patient’s cardiac output and hemodynamic profile. Strong evidence has demonstrated that these frequently occurring and often underdiagnosed events have significant prognostic value for mechanical ventilation outcomes and are strongly associated with prolonged ICU stays and hospital mortality. Halting the consequences of PVA relies on the correct identification and approach of its underlying causes. However, this often requires advanced knowledge of respiratory physiology and the evaluation of complex ventilator waveforms in patient–ventilator interactions, posing a challenge to intensive care practitioners, in particular, those less experienced. This review aims to outline the most frequent types of PVA and propose a clinical algorithm to provide physicians with a structured approach to assess, accurately diagnose, and correct PVA.

18 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VCVasco Salgado Costa
Vasco Salgado Costa
JCJosé Cidade
José Cidade
IMInês Miguel de Noronha Medeiros
Inês Miguel de Noronha Medeiros
PFPedro Fidalgo
Pedro Fidalgo
HMHugo Miguel de Noronha Moreira
Hugo Miguel de Noronha Moreira
PPPedro Póvoa
Pedro Póvoa
Background/Objectives: Pneumocystis jirovecii pneumonia (PJP) remains a major cause of morbidity and mortality in immunocompromised patients. Bronchoalveolar lavage (BAL) is the diagnostic gold standard but is invasive and often impractical in critically ill patients. Oropharyngeal wash (OW) polymerase chain reaction (PCR) offers a rapid, non-invasive alternative. We performed a systematic review focusing on this respiratory sample’s diagnostic accuracy and clinical utility. Methods: We searched PubMed, Scopus, Web of Science, Cochrane Library, and clinical trial registries including ClinicalTrials.gov and MedRxiv for studies of PCR-based P. jirovecii detection in OW samples from immunocompromised adults, using BAL or induced sputum as reference standards. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology was followed. Quality was assessed with Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2), and pooled sensitivity/specificity were estimated using a bivariate random-effects model. Results: Twelve studies (n = 633; 346 confirmed PJP cases) met the inclusion criteria. Most cohorts were human immunodeficiency virus (HIV)-positive. Pooled sensitivity was 68.3% (95% CI: 59.2–75.9) and specificity 91.8% (95% CI: 85.9–95.3); the area under the summary receiver operating characteristic curve (AUC) was 0.887. Diagnostic yield improved with pre-sample cough induction, 60-s gargling, early sampling before extended therapy, and higher fungal loads. Risk of bias was low, and no significant publication bias was detected. Conclusions: OW-based PCR delivers high specificity and moderate sensitivity for PJP diagnosis, offering a safe, scalable, and patient-friendly alternative when invasive testing is unfeasible. Optimizing collection protocols and expanding evaluation to non-HIV immunosuppressed populations could enhance its role as an early screening tool, enabling faster treatment decisions and reducing unnecessary antimicrobial exposure.

13 January 2026 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
VCVasco Salgado Costa
Vasco Salgado Costa
SSStefan J. Schaller
Stefan J. Schaller
RFRicard Ferrer
Ricard Ferrer

15 April 2025 in BMJ Case Reports
Verified
Journal Article
Closed access
IMInês Cota Medeiros
Inês Cota Medeiros
TMTeresa Miranda
Teresa Miranda
HMHugo Miguel de Noronha Moreira
Hugo Miguel de Noronha Moreira
VCVasco Salgado Costa
Vasco Salgado Costa

12 May 2026 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
VCVasco Salgado Costa
Vasco Salgado Costa
MKMartin C. J. Kneyber
Martin C. J. Kneyber
ATArnaud W Thille
Arnaud W Thille